Interestingly, psychotic experiences among the general population were found to depend on genetic risk for autism, schizophrenia, and neurodevelopmental disorders more widely, with a critical role of the cannabinoid receptor type 2 gene (CNR2) in increasing the risk of presenting with distressing psychotic experiences. Here, CNR2 is linked to neurodevelopmental disorder.